ArticleAquaculture nutrition2026
Effects of Dietary Vitamin A Concentration and Stress on Astaxanthin Utilization in Atlantic Salmon (
Article in Aquaculture nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effects of Dietary Vitamin A Concentration and Stress on Astaxanthin Utilization in Atlantic Salmon (Aquaculture nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diets with 30 and 60 ppm astaxanthin in combination with vitamin A (VA) concentrations of 6500, 35,000, and 100,000 IU/kg were fed to Atlantic salmon post smolts in seawater for 17 weeks. Flesh color (SalmoFan 27.1-27.5), astaxanthin concentration (3 mg/kg), retention (4.8% and 8.9% at 30 and 60 mg astaxanthin/kg respectively), and digestibility (29% and 12% at 30 and 60 mg astaxanthin/kg, respectively) were lowest at the highest dietary VA concentration. Increasing VA concentration in the diet also reduced the astaxanthin concentrations in liver and plasma, but not in intestine. Hepatocytes and enterocytes were isolated from fish fed the six diets and incubated for 48 h with radiolabeled astaxanthin to study metabolic transformation of astaxanthin in vitro. Astaxanthin was metabolized to idoxanthin, β-carotene, retinol, and retinal in both cell types, but astaxanthin made up a larger proportion of total radioactivity in hepatocytes than in enterocytes. Hepatocytes from salmon fed high VA in the diet had the highest astaxanthin concentration (39% of the radioactivity), whereas the highest VA concentration (6% of the radioactivity) was found in hepatocytes from fish that received the lowest dietary VA concentration. Enterocytes from salmon fed the medium VA diet, had highest concentrations of astaxanthin (17%-26%), retinol (6.4%-7%) and the lowest concentration of idoxanthin (14%-31%). After the 17-week feeding trial, salmon fed four of the diets (30 and 60 ppm astaxanthin in combination with 6500 and 100,000 IU/kg VA) were exposed to repeated stress (crowding and low oxygen) for a period of 5 weeks. Stress reduced the astaxanthin concentrations in muscle with around 0.5 mg/kg, except in salmon fed the diet with high VA and 60 ppm astaxanthin, which maintained an astaxanthin concentration of 3.3 mg/kg. Changes in the part of the carotenoid NMR spectrum in salmon exposed to stress indicated that stress affected the conversion of astaxanthin in interaction with dietary VA and astaxanthin. The effects of diet VA and astaxanthin concentration in combination with stress on gene expression in intestine, liver, and muscle were measured, and minor effects on several immune, stress, and metabolic genes were found.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.